Emkay Global has recommended hold rating on Ashok Leyland with a target price of Rs 659 in its research report dated November 05, 2015.
Posts tagged MC
Hold Ashok Leyland; target of Rs 84: Emkay Global (08-11-2015)
Hold Kotak Mahindra Bank; target of Rs 659 Edelweiss (08-11-2015)
Edelweiss has recommended hold rating on Kotak Mahindra Bank with a target price of Rs 659 in its research report dated October 30, 2015.
MF inflows sustain for record 18 mths; local buying at $9bn (08-11-2015)
According to a Deutsche Bank research report, inflows sustained into local equity MFs for a record 18th successive month.
Godrej Properties cuts net debt by Rs 700 cr in Sept qtr (08-11-2015)
The Mumbai-based developer plans to further reduce the debt by monetising the commercial assets in Mumbai, Kolkata and Chandigarh, its MD CEO Pirojsha Godrej said.
Maruti Alto overtakes M800 as best selling model in India (08-11-2015)
Launched in September 2000, the model touched cumulative sales of 29,19,819 units in October, 2015.
Cairn wants India to appoint arbitrator by Nov 11 (08-11-2015)
The British oil explorer late last month wrote to Finance Minister Arun Jaitley reminding him of government’s promise to appoint an arbitrator “soon” to resolve the issue.
Top 3 cos lose Rs 32,447 cr in m-cap; Sun Pharma hit hard (08-11-2015)
Sun Pharma saw its market valuation slump by Rs 20,526.9 crore to Rs 1,93,405.29 crore, taking the steepest hit in the top 10 list.
FPIs take out Rs 4,300 cr in just 5 trading days (08-11-2015)
The move comes after Foreign Portfolio Investors (FPIs) inflow had hit a 7-month high in October. As per data compiled by the depositories, net outflow in equities stood at Rs 2,667 crore between November 2-6, while it was Rs 1,689 crore for debt, translating into a total of Rs 4,356 crore (USD 666 million).
Essar Steel picks advisers to help sell stake, cut debt (08-11-2015)
Essar Steel is suffering along with much of the industry from the impact of Chinese over-supply and falling prices, and the group had already announced plans to raise funds by selling some of its non-core assets.
Sun Pharma Q2 net dips 46% to Rs 1,107 cr (08-11-2015)
The company had posted a net profit of Rs 2,050.22 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said in a statement.